Encompass Health Q2 EPS $0.95 Beats $0.74 Estimate, Sales $1.19B Beat $1.16B Estimate
Portfolio Pulse from Benzinga Newsdesk
Encompass Health (NYSE:EHC) reported Q2 earnings of $0.95 per share, beating the analyst consensus estimate of $0.74 by 28.38%. This is a 6.74% increase from the same period last year. The company also reported quarterly sales of $1.19 billion, beating the analyst consensus estimate of $1.16 billion by 1.98%, but this is a 10.82% decrease from the same period last year.
August 04, 2023 | 10:31 am
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Encompass Health's Q2 earnings and sales beat estimates, but sales are down 10.82% YoY. This mixed result could lead to uncertain market reactions.
Encompass Health's earnings beat estimates, which is typically a positive signal for the stock. However, the decrease in sales compared to the same period last year could be a concern for investors, potentially offsetting the positive earnings news. Therefore, the short-term impact on the stock is uncertain.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 100